Moesin is a member of the ezrin-radixin-moesin (ERM) family of cytoskeletal proteins. These proteins organize membrane domains by interacting with plasma membrane proteins and the actin cytoskeleton. Because of their high sequence similarity, ERM proteins are usually thought to be functionally redundant. Lymphocytes express two ERM proteins, ezrin and moesin. Whether each ERM plays a specialized role in lymphocytes, particularly in vivo, remains unknown. Here, we show that moesin has a crucial, non-redundant role in lymphocyte homeostasis. Moesin-deficient mice exhibited decreases in both T and B cells in the peripheral blood and lymph nodes, but not in the spleen. This phenotype was recapitulated in bone marrow (BM) chimeras with a hematopoietic moesin deficiency. Although the T and B cells apparently developed without major defects in the moesin-deficient mice, T cell egress from the thymus and immature B cell egress from the BM were impaired. In the periphery, both T and B cells showed delayed egress from lymphoid organs. We showed that moesin is the primary phosphorylated ERM subject to dynamic regulation during cell shape changes and migration. Our findings identify a previously unknown, non-redundant function of moesin in lymphocyte homeostasis in regulating lymphocyte egress from lymphoid organs.
Introduction
Peripheral lymphocytes must be maintained in appropriate numbers and diversity to support immunocompetence (1, 2) . This involves the constant and dynamic regulation of lymphocyte generation, differentiation, trafficking, survival and death. Newly produced lymphocytes must leave the primary lymphoid organs to populate the peripheral compartment. After T cells develop and mature in the thymus, they emigrate from it into the circulation. Newly formed B cells emigrate from the bone marrow (BM); initially, they home to the spleen where they mature primarily into follicular B cells, which then enter the circulation. Once in the periphery, these lymphocytes continually recirculate between the secondary lymphoid organs, entering and exiting the lymph nodes (LNs) and spleen (3) .
The egress of lymphocytes from the thymus and LNs requires a concentration gradient of sphingosine 1-phosphate (S1P) and S1P receptor 1 (S1PR1) (4) . FTY720, a small-molecule immunosuppressant, inhibits lymphocyte egress from lymphoid organs and induces peripheral lymphopenia by down-regulating S1PR1 (4) . Recently, the egress of immature B cells from the BM was also reported to require S1PR1 signaling (5, 6) . Beyond the requirement for the S1P-S1PR1 axis, however, little is understood about what molecules are involved or how they function in lymphocyte egress from lymphoid organs. Several recent observations suggest that molecules involved in reorganizing the actin cytoskeleton are also important for this egress: mice deficient in the formin protein mDia1, which promotes the formation of unbranched actin filaments, show defective thymic egress (7) , and those deficient in coronin 1A, which regulates the Arp2/3-mediated formation of branched actin filaments, exhibit defective T-cell egress from the thymus and LNs (8) . In addition, DOCK2, which activates the small G protein Rac, a key regulator of actin polymerization, is needed for egress from LNs (9) . Because the coronin 1A and DOCK2 deficiencies impair S1P-dependent lymphocyte migration, these proteins are likely to regulate actin reorganization in response to S1P.
The ezrin-radixin-moesin (ERM) proteins are a family of widely distributed membrane proteins that link membrane proteins and the actin filaments in the cell cortex, thereby regulating the structure and function of specific cell cortical domains (10) (11) (12) . ERM proteins have been implicated in many fundamental processes, including cell-shape determination, membrane-protein localization, membrane transport and signal transduction through their regulation of the cell cortex. Because of their high sequence similarity, ERM proteins are generally thought to be functionally redundant. This notion is supported by studies of mice deficient in individual ERM proteins, in which abnormalities are observed mostly in tissues and cell types that express only one ERM. Thus, radixin-deficient mice exhibit a defect in the secretion of conjugated bilirubin from hepatocytes, where radixin is the dominant ERM protein (13) . Ezrin deficiency causes defective epithelial organization and villus morphogenesis in the developing intestine, where ezrin is the only ERM protein (14) . Moesin-deficient mice were initially reported to display no obvious abnormalities (15) . More recently, they were reported to exhibit attenuated responses to liver injury because of the impaired migration of hepatic stellate cells, which express only moesin, among the ERM proteins (16) . Moesin is reported to be specifically expressed in the distal lung epithelium, where ezrin and radixin are only faintly detectable, and moesin-deficient mice exhibit abnormalities of the alveolar architecture and develop more severe lung injury than normal mice in a bleomycin-induced lung-injury model (17) .
Lymphocytes predominantly express two ERM members, ezrin and moesin (18) . These ERMs are implicated in the maintenance of microvilli, organization of proximal-distal polarity, regulation of cell death and antigen receptor signaling (12, 19) . The function of ERM proteins is regulated in part by phosphorylation, and chemokine stimulation of lymphocytes induces rapid dephosphorylation of ERMs, which facilitates loss of microvilli and polarization (20, 21) . In most cases, lymphocyte ezrin and moesin are regarded as functionally redundant. In mature T cells, ezrin and moesin show different distribution and phosphorylation patterns in response to TCR engagement, but they function mostly redundantly to promote T-cell activation (22) . Analysis of ezrin-deficient fetal liver chimeras indicated that ezrin is dispensable for T-cell development, despite its high expression in thymocytes, most likely due to redundancy with moesin (23) . In B cells, the knockdown of both ezrin and moesin results in decreased antigen aggregation and BCR microcluster formation, but the knockdown of either alone has no effect (24) . Whether each ERM protein in lymphocytes has a unique, specialized role, particularly in vivo, is unknown.
Here, we report that the deletion of moesin alone substantially affects lymphocyte homeostasis in vivo. Moesin-deficient mice exhibited lymphopenia in the peripheral blood. The hematopoietic moesin deficiency also caused lymphopenia, suggesting that moesin has a lymphocyte-intrinsic role in regulating lymphocyte homeostasis. The lymphopenia in moesin-deficient mice was at least partly caused by the impaired egress of lymphocytes from the thymus, BM and secondary lymphoid organs. We also show that moesin is the primary phosphorylated ERM (pERM) that is dynamically regulated during cell shape changes and migration. Our results identify a crucial role for moesin during lymphocyte egress and indicate that moesin plays a non-redundant role in lymphocyte homeostasis in vivo.
Methods

Mice, BM chimeras and splenectomy
Moesin-deficient mice were produced as described previously (15) 
Cell preparation and stimulation
Lymphocytes were isolated by mechanical disruption between the frosted ends of glass slides and filtration through 100-μm nylon mesh twice. The total cells were enumerated with a hemocytometer. For adoptive transfers and chemotaxis assays, the lymphocytes were further purified by centrifugation on Lympholyte-M (Cedarlane, Hornby, Ontario, Canada). For RT-PCR and western blot analyses, splenic CD4 + T, CD8 + T and B cells were isolated using the CD4 + T Cell Isolation Kit, CD8 + T Cell Isolation Kit and B Cell Isolation Kit (all from Miltenyi Biotec, Bergisch Gladbach, Germany), respectively. For pERM staining, cells were incubated for 2 h in RPMI 1640 media containing 10 mM HEPES and 0.1% fatty acid-free BSA and then stimulated with 10 nM S1P or 100 nM CXCL12 for the indicated times. For F-actin staining, cells were similarly prepared and stimulated with 500 nM S1P for the indicated times.
Quantitative real-time RT-PCR
Total RNA was isolated using the RNeasy Micro Kit (Qiagen, Valencia, CA, USA). RT was performed using the Transcriptor First Strand cDNA Synthesis Kit with random hexamers (Roche Diagnostics, Branchburg, NJ, USA). PCR was performed in a final volume of 20 μl containing the cDNA, 1× LightCycler 480 Probes Master (Roche Diagnostics) and 1× TaqMan Gene Expression Assay for ezrin (Ezr), radixin (Rdx) or moesin (Msn) (all from Applied Biosystems, Carlsbad, CA, USA) using a LightCycler 480 (Roche Diagnostics). The PCR conditions were 95°C for 5 min, followed by 45 cycles of 95°C for 10 s and 60°C for 25 s, and a final cooling step at 50°C for 15 s. Cyclophilin B (Ppib) was amplified as an internal control.
Western blotting analyses
Splenic CD4
+ T, CD8 + T and B cells were lysed in SDS sample buffer. The samples were resolved by SDS-PAGE, and the proteins were transferred to a Clearblot P membrane (Atto, Tokyo, Japan). The membranes were probed with a rabbit anti-moesin antibody (Q480, Cell Signaling Technology, Danvers, MA, USA), followed by HRP-conjugated anti-rabbit IgG (American Qualex, San Clemente, CA, USA), or a rat anti-ezrin mAb (M11, Sanko-junyaku, Tokyo, Japan), followed by HRP-conjugated anti-rat IgG (American Qualex).
Flow cytometry
The mAbs used for flow cytometric analyses were purchased from BD Biosciences (San Jose, CA, USA), eBioscience (San Diego, CA, USA) or BioLegend (San Diego, CA, USA). Single-cell suspensions were incubated with anti-CD16/CD32 for 10 min, stained with mAbs for 30 min on ice, and washed. Data were acquired on a FACSCalibur or LSRFortessa (both from BD Biosciences) and analyzed using FlowJo (Tree Star, Inc., Ashland, OR, USA). Whole-blood flow cytometry was performed as previously described (25) . Cell-surface S1PR1 staining was performed as previously described (26) . Briefly, cells were incubated with a rat mAb to S1PR1 (R&D Systems, Minneapolis, MN, USA) for 30 min at room temperature, and then stained with biotinylated anti-rat IgG (Jackson ImmunoResearch, West Grove, PA, USA) followed by allophycocyanin-conjugated streptavidin. Finally, the cells were surface-stained to enable identification of cell subsets. For intracellular staining of pERM, cells were fixed and permeabilized using the BD Cytofix/Cytoperm Fixation/ Permeabilization Kit and labeled with a rabbit antibody to pERM (Cell Signaling Technology) or control rabbit IgG (Chemicon, Temecula, CA, USA) followed by PE-labeled goat (Fab') 2 anti-rabbit IgG (Beckman Coulter, Fullerton, CA, USA). For F-actin staining, stimulated cells were immediately fixed and permeabilized using the BD Cytofix/Cytoperm Fixation/ Permeabilization Kit, and labeled with AlexaFluor 488 phalloidin (Invitrogen, Carlsbad, CA, USA).
BrdU labeling
For continuous BrdU labeling, 1 mg ml −1 of BrdU (SigmaAldrich, St Louis, MO, USA) was included in the drinking water. BrdU incorporation was determined with the BrdU Flow Kit (BD Biosciences).
Labeling of sinusoidal cell populations
Sinusoidal cells were labeled by injection of mice intravenously for 2 min with 1 μg PE-conjugated mouse anti-mouse CD45.2 (clone 104, BioLegend) in 200 μl PBS. Mice were immediately killed, and tissues were prepared for flow cytometry. lymphocytes (test population) were cotransferred with TRITC-labeled internal control lymphocytes (control population) into WT recipients. After 20 h, the LNs were collected from one group of mice and analyzed by flow cytometry (0 h). The other group received an i.p. injection of anti-α4 (clone M17/4, BioLegend) and anti-αL (clone PS/2, Serotec, Oxford, UK) mAbs (100 μg each per mouse in PBS) and was analyzed 24 h later (24 h). Data are presented as the 24-h ratio of the test population to control population divided by the 0-h ratio of the test population to control population for each subset.
Adoptive transfer and treatments
To determine the egress efficiency from the splenic white pulp, Msn +/Y or Msn −/Y lymphocytes were labeled with 2 μM CellTracker Orange CMTMR (Invitrogen) at 37°C for 25 min in RPMI containing 10% FCS and injected via the tail vein into B6 recipients. After 4 h, the spleen was collected from one group of mice (0 h). The other group received anti-α4 and anti-αL mAbs and was analyzed 36 h later (36 h). Cryostat sections of the spleen were fixed and stained with anti-MAdCAM-1 (clone MECA-89, BD Biosciences) followed by AlexaFluor 488-labeled goat anti-rat IgG (Invitrogen), and the transferred cells in the white pulp cords were enumerated.
Chemotaxis assays
Transwell migration assays were performed as previously described (27) . In brief, lymphocytes (1 × 10 6 cells per well) were loaded into 5-μm Transwells (Corning Costar Corp., Corning, NY, USA) coated with 10 μg ml −1 fibronectin and allowed to migrate for 4 h to S1P, chemokines or medium in the bottom chamber. Cells that migrated were harvested and counted on a hemocytometer, and subsets were determined by flow cytometry. Transwell assays were performed in triplicate for each concentration.
Scanning electron microscopy
were sorted by FACSAria and incubated in RPMI with 10 mM HEPES and 0.1% fatty acid-free BSA for 3 h before stimulation. Cells were stimulated with CXCL12 or S1P for 10 min and pre-fixed with 1% glutaraldehyde in 0.1 M phosphate buffer at 20°C for 20 min. The cells were attached to poly-l-lysine-pretreated glass plates and post-fixed by 2% glutaraldehyde in 0.1 M phosphate buffer at 20°C for 30 min and 1% OsO 4 in 0.1 M phosphate buffer at 20°C for 60 min, followed by dehydration through a graded ethanol series and drying by critical point dryer (HCP-2, Hitachi, Kyoto, Japan). The specimens were coated with 250 Å of gold by an ion sputtering device (IB-3, Eiko, Ibaragi, Japan) and were examined with a scanning electron microscope (S-3000H, Hitachi) at an accelerating voltage of 25 kV.
Results
Moesin deficiency impairs lymphocyte homeostasis
Lymphocytes predominantly express ezrin and moesin, and little or no radixin (18) . The moesin deficiency did not significantly alter the expression of either ezrin or radixin in lymphocytes ( Fig. 1A and B). The peripheral blood from moesin-deficient mice showed a reduction in the total leukocyte count, to 43% of the level in littermate controls (Fig. 1C ). The number of cells was decreased in all leukocyte subsets examined, except for the Gr-1 + monocyte subset. The reduction was particularly pronounced for lymphocytes, with CD8 + T cells showing the most prominent decrease, to 32% of the control level, while the reduction in neutrophil and eosinophil counts was milder. A reduction in cell numbers was also observed in some secondary lymphoid organs of the moesin-deficient mice, including the peripheral LN (PLN) and mesenteric LN (MLN), with decreased numbers of B cells and of CD4 + and CD8 + T cells ( Fig. 1D and E) . In contrast, the spleen contained increased numbers of lymphocytes, suggesting that the numbers of lymphocytes in lymphoid organs are skewed in moesin-deficient mice. The BM and thymus contained normal numbers of cells (Fig. 1D) .
To test whether the reduction in B and T cells in the periphery was due to their accumulation in the spleen, we performed a neonatal splenectomy and analyzed the peripheral blood 8 weeks later. Although the total leukocyte count was higher and more variable in the splenectomized mice than in untreated mice, the splenectomized moesin-deficient mice still exhibited leukopenia compared with the splenectomized littermate controls, with reduced numbers of B and T cells (Fig. 1F) . These results indicate that lymphopenia was not exclusively a result of splenic accumulation and point to a role for moesin in lymphocyte homeostasis independent of its role in peripheral lymphocyte distribution.
Moesin is abundant in cells of hematopoietic origin, but it is also expressed in other cell types, including endothelial cells (28) . To determine whether the impaired lymphocyte homeostasis observed in moesin-deficient mice was due to intrinsic defects in the lymphocytes, BM chimeras were analyzed. Transplanting BM cells from moesin-deficient mice into lethally irradiated WT CD45.1 mice recapitulated the peripheral blood lymphopenia, with reductions in both B and T cells, whereas lethally irradiated moesin-deficient mice receiving WT CD45.1 BM cells did not exhibit this phenotype ( Fig. 1G; Supplementary Figure 1A is available at International Immunology Online). Moreover, the LNs of the hematopoietic moesin-deficient BM chimeras showed decreased numbers of B and T cells, but the spleen did not (Fig. 1H) , reminiscent of the situation in moesin-deficient mice. In the moesin-deficient mice with WT BM, no reduction in lymphocyte numbers was observed in the LNs (Supplementary Figure 1B is available at International Immunology Online). These results suggest that moesin functions cell-autonomously in lymphocytes, in the regulation of both B-and T-cell homeostasis.
Moesin regulates naive T-cell homeostasis
Further analysis of the CD4 + and CD8 + T cells in the blood of moesin-deficient mice revealed a lower proportion of CD44 lo CD45RB hi naive cells and a higher proportion of CD44 hi activated-memory cells than in the littermate controls and thus the number of naive CD4 + and CD8 + T cells was more severely reduced than that of activated-memory cells in moesin deficiency (Fig. 2A) . The reduction of CD4 + and CD8 + T cells in LNs was also mostly attributable to the reduced numbers of naive cells (Fig. 2B) . The hematopoietic moesin deficiency resulted in decreased numbers of naive CD4
+ and CD8 + T cells in both the LNs and spleen ( 
Defective thymic egress in moesin-deficient mice
To determine whether the observed peripheral phenotype could arise from a defect in thymic differentiation, we examined thymic subsets in the moesin-deficient mice. A previous study showed that ezrin and moesin are differentially expressed during thymocyte development: ezrin mRNA is high in the double-negative (DN) and double-positive (DP) subsets, and decreases in the single-positive (SP) populations, while moesin mRNA shows the opposite pattern (23) . Using antibodies that specifically recognize moesin (Supplementary Figure 3A is available at International Immunology Online), we confirmed that the moesin expression was high in the DN subset 1 and decreased in the DN subsets 2-4 and DP stages, but increased again in the SP populations (Supplementary Figure 3B is available at International Immunology Online). The moesin deficiency did not affect the numbers or proportions of cells in the DN, DP and SP subsets (Supplementary Figure 3C and D, available at International Immunology Online), suggesting that moesin is dispensable for T-cell development. Histological analysis also indicated that loss of moesin did not affect the overall thymic architecture (Supplementary Figure 3E is available at International Immunology Online). As ezrin was also shown to be dispensable for T-cell development in the thymus (23) , it is possible that ezrin and moesin function redundantly during T-cell development.
The remarkable increase in moesin expression in thymocytes as they mature suggested that moesin might have a specific role in mature T cells. Further analysis of the SP populations revealed that the proportion and number of mature CD62L hi CD69
lo CD4 SP cells were increased in the moesin-deficient mice (Fig. 3A) . The proportion and number of mature CD8 SP cells were also increased (Fig. 3A) . A thymic accumulation of mature SP cells is a hallmark of mice in which egress from the thymus is defective, such as transgenic mice that express the catalytic subunit of the pertussis toxin in thymocytes (29) and hematopoietic S1PR1-deficient mice (27) . The expression of S1PR1 is known to be up-regulated in mature thymocytes (30) . Although the total S1PR1 expression in each subset was similar between moesin-deficient and WT mice (Supplementary Figure 3F is available at International Immunology Online), the proportion of cells expressing cell-surface S1PR1, which are thought to be egress competent, was increased in the mature CD4 SP and CD8 SP populations of moesin-deficient mice (Fig. 3B) , further suggesting that egress from the thymus is impaired in these mice.
To exclude the possibility that the accumulation of mature SP cells resulted from an increased proliferation of SP cells, we treated mice with BrdU continuously for 9 days, to label proliferating cells. We found that, although the DP subset was labeled similarly, smaller percentages of cells in the CD4 SP and CD8 SP populations were labeled in the moesin-deficient mice than in littermate controls, (Fig. 3C) . These unlabeled cells were mostly found in mature populations (Fig. 3D) . A previous study showed that SP thymocytes emigrate 4-5 days after entering the SP pool (31) . The increase in BrdU-unlabeled mature SP cells is consistent with an egress defect, but not with increased proliferation of these cells. We concluded that moesin plays a role in thymic emigration.
Moesin controls BM egress of immature B cells
As B-cell numbers were also decreased in the blood of moesin-deficient mice, we next sought to assess the involvement of moesin in B-cell homeostasis. Analysis of B-cell subpopulations in the peripheral blood of moesindeficient mice showed a significant decrease in recirculating mature IgD hi B cells and immature IgD lo B cells, whereas pro-/pre-B cells and immature IgD − B cells were present at comparable numbers (Fig. 4A) . The hematopoietic moesin deficiency resulted in a similar decrease in mature IgD hi and immature IgD lo B cells (Fig. 4B) . Previous studies showed that immature B cells are released from the BM into the circulation, which then enter the spleen to differentiate into mature cells (32, 33) . The reduced number of immature IgD lo B cells in the blood raises the possibility of a defect in their release from the BM.
In developing BM B cells, the moesin expression increased, with the highest expression observed in immature IgD lo B cells (Supplementary Figure 4 is available at International Immunology Online). The BM of moesin-deficient mice exhibited a slightly increased number of pro-B cells and normal numbers of pre-B and immature IgD − B cells (Fig. 4C ). Mature recirculating B cells were significantly reduced, in accordance with their reduced number in the peripheral blood. As immature B cells are thought to emigrate from the BM parenchyma into sinusoids, and then into the circulation, Values are means ± SEM from eight mice (A) and four mice (B and C). *P < 0.05, **P < 0.01, ***P < 0.001. we analyzed the distribution of immature B cells in the BM parenchyma and sinusoids of moesin-deficient mice using an established method to selectively label sinusoidal cells by injecting PE-labeled anti-CD45.2 mAb (6, 33) . We found that the number of immature IgD − and IgD lo B cells in the sinusoids was reduced, while that in the parenchyma was not significantly affected (Fig. 4D) . These results may indicate impaired egress from the BM parenchyma into sinusoids. However, an accumulation of immature B cells in the BM parenchyma was not evident, which might be expected to occur if egress from the parenchyma to sinusoids was defective. We found that the annexin V + fraction was increased in the immature IgD lo B-cell population, but not in other populations including the pro-B, pre-B and immature IgD − B cells, in the moesin-deficient BM (Fig. 4E) . Increased apoptosis of immature IgD lo B cells may explain the lack of their accumulation in the moesin-deficient BM.
To further evaluate the B-cell egress behavior, we labeled rapidly proliferating B cells with BrdU for 48 h and determined the number of BrdU-labeled cells in the BM and peripheral blood. In the BM parenchyma of moesin-deficient mice, the number of BrdU + cells was higher in the pre-B and immature IgD − populations (Fig. 4F) , suggesting that B-cell proliferation is enhanced. However, the number of BrdU + immature IgD − and IgD lo B cells in the sinusoids and that of IgD lo B cells in the blood were decreased (Fig. 4F) , further supporting the view that immature B-cell egress is impaired in the moesin-deficient mice.
Moesin is required for efficient lymphocyte egress from secondary lymphoid organs
As egress from primary and secondary lymphoid organs shares many mechanisms, we next examined the impact of moesin deficiency on peripheral lymphocyte trafficking. We transferred moesin-deficient or WT littermate lymphocytes together with internal control cells into WT recipients. At 1 h after transfer, the ratio of moesin-deficient naive CD4 + T cells to control cells in the LNs was decreased compared with that of littermate cells, while no significant differences were observed for naive CD8 + T cells and B cells (Fig. 5A ). Homing to the spleen was also not significantly affected by the moesin deficiency, for any cell type (Fig. 5A) . These findings suggested that moesin plays a relatively minor role in lymphocyte entry into these organs. The moesin deficiency did not affect the expression level of adhesion molecules implicated in lymphocyte homing, including integrins, CD43, CD44 and CD162, with the exception of CD62L (Supplementary Figure 5A is available at International Immunology Online). The CD62L expression level was increased in both B and T cells from moesin-deficient mice (Supplementary Figure 5B is available at International Immunology Online), which may potentially compensate for any homing defects. Integrin activity determined by VCAM-1 and ICAM-1 binding was also not significantly affected by the moesin deficiency (Supplementary Figure 5C and D is available at International Immunology Online).
To examine the efficiency of egress, we administered integrin-blocking mAbs 20 h after cell transfer, to block lymphocyte entry into the LNs, and examined the retention rate of the cells for the following 24 h. Moesin-deficient naive CD4 + and CD8 + T cells as well as B cells exhibited a much higher rate of retention in LNs compared with the littermate control cells (Fig. 5B) , indicating that the moesin-deficient lymphocytes had an egress defect. As lymphocyte entry into the splenic white pulp is also integrin-dependent (34), we examined the efficiency of egress from the splenic white pulp by enumerating the transferred cells that remained in the white pulp area 36 h after the administration of integrin-blocking mAbs. The number of moesin-deficient lymphocytes retained in the splenic white pulp was also higher than that of control cells (Fig. 5C) . These results together establish that moesin plays a role in lymphocyte egress from the secondary lymphoid organs in addition to its role in thymic and BM egress and therefore explain at least in part the lymphopenia observed in moesin-deficient mice.
Defective cell cortex changes in moesin-deficient lymphocytes upon stimulation
It is well established that lymphocyte egress requires S1PR1 (4). The chemotactic response of moesin-deficient naive CD4 + and CD8 + T cells in Transwell assays, expressed as the chemotactic index, was decreased compared with that of WT cells (Fig. 6A) . The chemotactic index of moesin-deficient naive CD4
+ and CD8 + T cells to the homeostatic chemokines CXCL12 and CCL21 was also reduced (Fig. 6B) . Follicular B cells hardly responded to S1P, regardless of the genotype, while WT marginal zone B cells efficiently migrated (Fig. 6A) . The chemotactic index of moesin-deficient B cells to CXCL12 and CCL21 was also decreased (Fig. 6B) . Thus, the directed migration of moesin-deficient lymphocytes may not be as efficient as WT cells. Altered chemotactic responses were unlikely to be due to the changes in chemokine receptor expression, as the cell-surface expression of CXCR4, CCR7 and S1PR1 was not significantly different between moesindeficient cells and WT cells (Supplementary Figure 6 is available at International Immunology Online).
Cell migration is well known to be associated with shape changes (35) . Since spherical morphology and polarization are partly regulated by the phosphorylation status of ERM proteins (20) , we next examined pERM levels in lymphocytes. The pERM content of resting moesin-deficient T and B cells was markedly lower than that of WT littermate cells (Fig. 6C) , indicating that moesin is the dominant pERM in lymphocytes. Upon stimulation with S1P and CXCL12, pERM levels rapidly decreased within 1 min and gradually returned to the basal levels in WT cells, while minimal changes were observed in moesin-deficient cells (Fig. 6D) . In accordance with a dramatic reduction in basal pERM levels, scanning electron microscopy revealed a few and undeveloped microvilli in unstimulated moesin-deficient cells (Fig. 6E) . When stimulated with CXCL12, many WT cells polarized, while polarization was less evident in moesin-deficient cells. Strikingly, S1P stimulation induced prominent membrane ruffling in WT cells, which was hardly observed in moesin-deficient cells (Fig. 6E) . In addition, F-actin formation in response to S1P was decreased in moesin-deficient cells (Fig. 6F) . These results indicate that moesin is required for membrane reorganization upon stimulation with chemokines and S1P and may suggest that appropriate regulation of the cell cortex in response to these stimulants is important for lymphocyte egress.
discussion
Lymphocytes predominantly express two ERM proteins, ezrin and moesin, which are regarded as functionally redundant. We show here that moesin-deficient mice as well as BM chimeras reconstituted with moesin-deficient BM exhibited alterations in lymphocyte homeostasis, characterized by peripheral blood lymphopenia. This is in sharp contrast to the phenotype of ezrin-deficient fetal liver chimeras, which showed normal lymphocyte counts and distribution in peripheral blood and lymphoid organs (23) . We provide evidence that the lymphopenia phenotype of moesin-deficient mice was most likely caused by impaired egress of lymphocytes from lymphoid organs, including the thymus, BM and secondary lymphoid organs, such as the spleen and LNs. These observations identify a unique, non-redundant role for moesin in vivo.
Our studies provide important insights regarding the role of moesin in the regulation of lymphocyte egress. The accumulation of mature CD4 and CD8 SP cells and the increase in BrdU-unlabeled mature SP cells in the thymus of moesin-deficient mice strongly suggest an egress defect. Compared with previously reported mice with a phenotype of defective egress from the thymus, such as those deficient in S1PR1 or coronin 1A, which show an increase in the total SP cell number (8, 27) , the increase in the cell number was observed only in mature SP populations in moesin-deficient mice, suggesting that the egress defect is relatively mild. Lymphocytes from mice deficient in S1PR1, DOCK2 or coronin 1A exhibit an impaired response to S1P in chemotaxis assays (8, 9, 27) . In contrast, lymphocytes lacking MST1, a kinase involved in lymphocyte adhesion and polarization, show a defect in thymic egress but respond normally to S1P (36) , suggesting that chemotactic responsiveness to S1P is not sufficient for lymphocyte egress. Several homeostatic chemokines, such as CXCL12 and CCR7 ligands, are also known to be involved in thymic egress (37, 38) . Lymphocytes lacking DOCK2, coronin 1A or mDia, which are regulators of actin reorganization, show a generalized impairment in their chemotactic responses to homeostatic chemokines (7) (8) (9) , and those lacking MST1 show a defective response to CCR7 ligands (36) . Although moesin-deficient lymphocytes show a decrease in the chemotactic index to S1P and chemokines, they appear to retain a higher degree of S1P and chemokine responsiveness compared with those from previously reported egress-defective mice, which may partly explain the relatively mild egress defect in moesin-deficient mice.
The egress defect of moesin-deficient cells was not confined to T cells. Immature B cells are released from the BM into the circulation and this process requires the S1P-S1PR1 pathway (5, 6) . Our study demonstrated that a deficiency of moesin impairs immature B cell egress from the BM and enhances apoptosis of retained immature B cells. This phenotype is very similar to that reported for B cell-specific S1PR1-deficient mice (6) , suggesting that moesin plays a role in the S1PR1-mediated signal necessary for the efficient egress of immature B cells from the BM. In this regard, it is of note that S1PR1-deficient BM immature B cells migrate to S1P similarly to WT cells in Transwell chemotaxis assays (6) , suggesting that the S1PR1-mediated signal not measured by in vitro chemotaxis assays is critical for BM B-cell egress.
In addition to thymic and BM egress, moesin plays a role in the lymphocyte egress from secondary lymphoid organs. Direct egress assays showed that lymphocyte egress from both the spleen and LNs was impaired in moesin-deficient mice. The observation that the spleen of moesin-deficient mice rather contains increased numbers of lymphocytes suggests that the lymphocyte egress from this organ is more prominently impaired than that from LNs. Indeed, our preliminary long-term lymphocyte trafficking assays showed that moesin-deficient lymphocyte were likely to be retained in secondary lymphoid organs during circulation, and that they were particularly well retained in the spleen.
The identification of a critical role for moesin in lymphocyte egress from lymphoid organs provides evidence that emigration from these organs depends on proper regulation of the cell cortex. Although a previous study showed that moesin-deficient mast cells exhibit normal microvilli (15), we Values are means ± SEM from four mice (A and B) and three mice (C). *P < 0.05, **P < 0.01, ***P < 0.001. showed here that moesin-deficient lymphocytes are defective in the formation of microvilli. Thus, among hematopoietic cells, the relative contribution of ezrin and moesin may depend on the cell type. Indeed, the reduction of myeloid cells in the peripheral blood of moesin-deficient mice was milder than that of lymphoid cells. ERM activity is regulated in part by phosphorylation at a C-terminal threonine (19) . pERM proteins are thought to contribute to the maintenance of microvilli, and chemotactic factor stimulation induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization (20) . An almost complete loss of pERM in moesin-deficient lymphocytes indicates that moesin is the major pERM in unstimulated lymphocytes. Accordingly, moesin-deficient lymphocytes exhibit minimal dephosphorylation of ERM proteins upon chemotactic factor stimulation. Furthermore, F-actin polymerization upon stimulation was decreased in moesin-deficient lymphocytes. The observation that moesin-deficient lymphocytes showed minimal morphological changes when stimulated with chemokines and S1P suggests that dynamic regulation of moesin activity is critical for actin polymerization and these morphological changes, and possibly for efficient egress of lymphocytes. The requirement for dynamic regulation of the ERM phosphorylation status for cell migration has also been supported by recent reports showing that transgenic T cells expressing phosphomimetic ezrin are impaired in migration and egress in vivo (39) and that inhibition of ERM dephosphorylation impairs B-cell migration in response to CXCL13 (40) .
Although ERM proteins are known to link various adhesion molecules involved in lymphocyte homing and leukocyte migration, such as CD62L, CD162, CD43 and CD44, to the cortical cytoskeleton, lymphocyte homing was only marginally affected by the moesin deficiency, suggesting that ezrin and moesin are redundant in anchoring these proteins, or that cytoskeletal anchoring is not critical for efficient lymphocyte homing. Given that the CD62L surface expression is increased in moesin-deficient cells, it is also possible that homing defects are alleviated by increased L-selectin activity. This may be attributable to reduced shedding efficiency, as CD62L binding to ERMs is important for shedding (41, 42) .
In summary, our findings establish that moesin, which has been thought to function mostly redundantly with ezrin in lymphocytes, plays a critical, non-redundant role in regulating lymphocyte homeostasis and immune responses. The involvement of moesin in the process of lymphocyte egress adds this molecule to the expanding category of egress-regulating molecules. Given that our current understanding of lymphocyte egress is still limited, beyond the known requirement for S1P-S1PR1 signaling, clarifying the molecular mechanism by which the ERM protein moesin regulates lymphocyte egress will lead to a better understanding of this important homeostatic process, which is also a target process for immunosuppressive drugs.
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